SCHEMBL15848968

SCHEMBL15848968

CCCn1c2ccc3c(c2c2c4c(ccc21)C(=O)CC4)CCC3=O

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TP53 P04637 1/20 0.44
ALDH1A1 P00352 3/20 0.38
HPGD P15428 3/20 0.38
KDM4E B2RXH2 2/20 0.38
ACHE P22303 1/20 0.34
CNR2 P34972 1/20 0.33
GAA P10253 1/20 0.33
MEN1 O00255 1/20 0.33
MAPK1 P28482 1/20 0.33
RAB9A P51151 1/20 0.33
KMT2A Q03164 1/20 0.33
L3MBTL1 Q9Y468 1/20 0.33
KDR P35968 2/20 0.32
TEK Q02763 2/20 0.32
PDE5A O76074 1/20 0.32
LMNA P02545 1/20 0.32
MAPT P10636 1/20 0.32
HTT P42858 1/20 0.32
GFER P55789 1/20 0.32
NPC1 O15118 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16131471 0.87 TP53 (0.46) TP53ALDH1A1HPGDKDM4ECNR2
SCHEMBL13419125 0.86 TP53 (0.40) TP53ALDH1A1HPGDKDM4EMAPK1
SCHEMBL12608633 0.84 TP53 (0.44) TP53ALDH1A1HPGDKDM4EMEN1
SCHEMBL13419001 0.84 TP53 (0.42) TP53ALDH1A1HPGDKDM4E
SCHEMBL30721748 0.84 TP53 (0.43) TP53ALDH1A1HPGDKDM4EACHE
SCHEMBL13418996 0.84 TP53 (0.41) TP53ALDH1A1HPGDKDM4EGAA
SCHEMBL12608711 0.84 TP53 (0.43) TP53ALDH1A1HPGDKDM4EACHE
SCHEMBL13419209 0.83 TP53 (0.39) TP53ALDH1A1HPGDKDM4ECNR2
SCHEMBL14472313 0.83 WEE1 (0.44) TP53ALDH1A1HPGDKDM4EMEN1
SCHEMBL16131452 0.83 ADORA1 (0.37) TP53ALDH1A1KDM4ECNR2GAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20170165229-A1 CARBAZOLE COMPOUNDS AND THERAPEUTIC USES OF THE COMPOUNDS INCURON, INC. 2017-06-15 US disclosed
US-9566265-B2 Carbazole compounds and therapeutic uses of the compounds INCURON, LLC (US) 2017-02-14 US disclosed
US-20150342927-A1 CARBAZOLE COMPOUNDS AND THERAPEUTIC USES OF THE COMPOUNDS INCURON, INC. 2015-12-03 US disclosed
US-9108916-B2 Carbazole compounds and therapeutic uses of the compounds INCURON, LLC (US) 2015-08-18 US disclosed
US-20140303224-A1 CARBAZOLE COMPOUNDS AND THERAPEUTIC USES OF THE COMPOUNDS INCURON, LLC (US) 2014-10-09 US disclosed
US-8765738-B2 Carbazole compounds and therapeutic uses of the compounds INCURON, LLC (US) 2014-07-01 US disclosed
US-20110305661-A1 Carbazole Compounds and Therapeutic Uses of the Compounds INCURON, INC. 2011-12-15 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170165229-A1 CARBAZOLE COMPOUNDS AND THERAPEUTIC USES OF THE COMPOUNDS MALT1, PAICS, BCL9 TP53 28/4885ALDH1A1 633/4885HPGD 212/4885
US-20150342927-A1 CARBAZOLE COMPOUNDS AND THERAPEUTIC USES OF THE COMPOUNDS MALT1, PAICS, BCL9 TP53 28/4885ALDH1A1 633/4885HPGD 212/4885
US-20110305661-A1 Carbazole Compounds and Therapeutic Uses of the Compounds MALT1, PAICS, TPMT TP53 33/4885ALDH1A1 589/4885HPGD 208/4885
US-20140303224-A1 CARBAZOLE COMPOUNDS AND THERAPEUTIC USES OF THE COMPOUNDS MALT1, PAICS, BCL9 TP53 28/4885ALDH1A1 633/4885HPGD 212/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.